# Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL

> **NCT03042585** · NA · COMPLETED · sponsor: **Loyola University** · enrollment: 17 (actual)

## Conditions studied

- Relapsed Non Hodgkin Lymphoma
- Refractory Non-Hodgkin Lymphoma

## Interventions

- **RADIATION:** Total body irradiation

## Key facts

- **NCT ID:** NCT03042585
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03042585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03042585, "Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03042585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*